Estônia -
estoniano -
Ravimiamet
herbion luuderohi siirup
krka d.d. novo mesto - luuderohuleht - siirup - 7mg 1ml 150ml 1tk
Estônia -
estoniano -
Ravimiamet
herbion luuderohi loseng
krka d.d. novo mesto - luuderohuleht - loseng - 35mg 8tk; 35mg 16tk; 35mg 40tk; 35mg 32tk
Estônia -
estoniano -
Ravimiamet
pectolvan siirup
farmak international sp. z o.o. - luuderohuleht - siirup - 7mg 1ml 100ml 1tk
Estônia -
estoniano -
Ravimiamet
helituspan siirup
sopharma ad - luuderohuleht - siirup - 7mg 1ml 120ml 1tk
Estônia -
estoniano -
Ravimiamet
hedelix kihisev tablett
krewel meuselbach gmbh - luuderohuleht - kihisev tablett - 50mg 10tk; 50mg 100tk; 50mg 24tk; 50mg 12tk
Estônia -
estoniano -
Ravimiamet
bronchipret duo siirup
bionorica se - aed-liivateeürt+luuderohuleht - siirup - 168mg+16,8mg 1ml 50ml 1tk; 168mg+16,8mg 1ml 100ml 1tk
Estônia -
estoniano -
Ravimiamet
bronchipret comp siirup
bionorica se - aed-liivateeürt+luuderohuleht - siirup - 168mg+16,8mg 1ml 50ml 1tk
Estônia -
estoniano -
Ravimiamet
hedelix siirup
krewel meuselbach gmbh - luuderohuleht - siirup - 8mg 1ml 100ml 1tk
União Europeia -
estoniano -
EMA (European Medicines Agency)
prevexxion rn
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunoloogilised ained - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).
União Europeia -
estoniano -
EMA (European Medicines Agency)
prevexxion rn+hvt+ibd
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.